Description
Octaplas LG O (I) Solution for Infusions 45-70 mg. 200 ml
Ingredients
- Octaplas LG O (I) solution contains essential plasma proteins such as albumin, immunoglobulins, clotting factors, and other proteins vital for maintaining plasma osmotic pressure and supporting various physiological functions.
Dosage
- The recommended dosage of Octaplas LG O (I) solution for infusions is 45-70 mg per 200 ml. Dosage may vary based on the patient’s condition, weight, and medical history. It is crucial to follow the healthcare provider’s instructions for the correct administration.
Indications
- Octaplas LG O (I) solution is indicated for the replacement or supplementation of plasma proteins in patients with congenital deficiencies, liver disease, or critical illnesses requiring plasma volume expansion.
Contraindications
- Do not use Octaplas LG O (I) solution in patients with a history of hypersensitivity to plasma-derived products or any component of the solution. Caution is advised in patients with selective immunoglobulin A deficiency.
Directions
- Octaplas LG O (I) solution is for intravenous use only. It should be administered by healthcare professionals trained in the administration of blood and blood products. The infusion rate should be adjusted based on the patient’s response and vital signs.
Scientific Evidence
- Studies have shown that Octaplas LG O (I) solution is effective in maintaining or restoring adequate levels of plasma proteins in patients with various medical conditions. Research has demonstrated its role in improving outcomes in patients with liver failure, sepsis, and other critical illnesses.
Additional Information
- Octaplas LG O (I) solution undergoes stringent quality control measures to ensure the safety and efficacy of the product. It is essential to monitor patients receiving Octaplas LG O (I) solution for any signs of adverse reactions or complications during infusion.
